ArticlePharmaceutics2022

Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study.

Vanesa Escudero-Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.